Impact of microRNAs on the understanding and treatment of rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 25, Issue 2, 2013, Pages 225-233

  Ammari, Meryem ^a,b   Jorgensen, Christian ^a,b   Apparailly, Florence ^a,b  

^a HÔPITAL SAINT ELOI   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

biomarker; miRNA; pathogenesis; rheumatoid arthritis; treatment

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MICRORNA; MICRORNA 124; MICRORNA 132; MICRORNA 133A; MICRORNA 142 3P; MICRORNA 146A; MICRORNA 150; MICRORNA 155; MICRORNA 16; MICRORNA 203; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 23B; MICRORNA 26A; MICRORNA 323 3P; MICRORNA 34A; MICRORNA 363; MICRORNA 498; PROTEIN SH2; STROMELYSIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; BIOGENESIS; BONE METABOLISM; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CIRCULATION; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUPUS ERYTHEMATOSUS; MONOCYTE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; RNA STRUCTURE; SJOEGREN SYNDROME; SYNOVIAL FLUID; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE REMODELING; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MICE; MICRORNAS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 84873406120     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835d8385     Document Type: Review

References (46)

1. Plant D, Flynn E, Mbarek H, et al. Investigation of potential non-HLA rheu-matoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 2010; 69:1548-1553.
2. Klareskog L, Alfredsson L, Rantapää-Dahlqvist S, et al. What precedes develop-ment of rheumatoid arthritis? Ann Rheum Dis 2004; 63 (Suppl. 2):ii28-ii31.
3. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetictransgenerational actionsofenvironmentalfactors in diseaseetiology. Trends Endocrinol Metab 2010; 21:214-222.
4. Ospelt C, Reedquist KA, Gay S, et al. Inflammatory memories: is epigenetics the missing linkto persistent stromal cell activation in rheumatoid arthritis? Autoimmun Rev 2011; 10:519-524.
5. Jüngel A, Ospelt C, Gay S. What can we learn from epigenetics in the year 2009? Curr Opin Rheumatol 2010; 22:284-292.
6. Duroux-Richard I, Jorgensen C, Apparailly F. What do microRNAs mean for rheumatoid arthritis? Arthritis Rheum 2012; 64:11-20.
7. Bhanji RA, Eystathioy T, Chan EK, et al. Clinical and serological features of patientswith autoantibodies to GW/P bodies. Clin Immunol 2007; 125:247-256.
8. Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8:467-477.
9. Pauley KM, Satoh M, Chan AL, et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008; 10:R101.
10. Murata K, Yoshitomi H, Tanida S, et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2010; 12:R86.
11. Zhu S, Pan W, Song X, et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med 2012; 18:1077-1086.
12. Niimoto T, Nakasa T, Ishikawa M, et al. MicroRNA-146a expresses in inter-leukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculos-kelet Disord 2010; 11:209.
13. Niederer F, Trenkmann M, Ospelt C, et al. Down-regulation of microRNA-34a&z. ast; in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis Rheum 2012; 64:1771-1779.
14. Nakamachi Y, Kawano S, Takenokuchi M, et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 2009; 60:1294-1304.
15. Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008; 58:1001-1009.
16. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA-146 in rheu-matoid arthritis synovial tissue. Arthritis Rheum 2008; 58:1284-1292.
17. + T cells from patients with rheumatoid arthritis. Arthritis Res Ther 2010; 12:R81.
18. Kurowska-Stolarska M, Alivernini S, Ballantine LE, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci USA 2011; 108:11193-11198.
19. Stanczyk J, Ospelt C, Karouzakis E, et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 2011; 63:373-381.
20. Pandis I, Ospelt C, Karagianni N, et al. Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the humantumournecrosisfactortransgenic mouse model. Ann Rheum Dis 2012; 71:1716-1723.
21. Fulci V, Scappucci G, Sebastiani GD, et al. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 2010; 71:206-211.
22. Shibuya H, Nakasa T, Adachi N, et al. Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation. Mod Rheu-matol 2012.
23. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356-361.
24. Baltimore D, Boldin MP, O'Connell RM, et al. microRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9:839-845.
25. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316:608-611.
26. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-KB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103:12481-12486.
27. Martinez-Nunez RT, Louafi F, Friedmann PS, et al. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN). J Biol Chem 2009; 284:16334-16342.
28. O'Connell RM, Chaudhuri AA, Rao DS, et al. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 2009; 106:7113-7118.
29. Blüml S, Bonelli M, Niederreiter B, et al. Essential roleof microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum 2011; 63:1281-1288.
30. Hou J, Wang P, Lin L, et al. MicroRNA-146afeedbackinhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009; 183:2150-2158.
31. Curtale G, Citarella F, Carissimi C, et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010; 115:265-273.
32. Suzuki Y, Kim HW, Ashraf M, et al. Diazoxide potentiates mesenchymal stem cell survival viaNF-kappaB-dependentmiR-146aexpression bytargeting Fas. Am J Physiol Heart Circ Physiol 2010; 299:H1077-H1082.
33. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451:1125-1129.
34. Dai R, Phillips RA, Zhang Y, et al. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008; 112: 4591-4597.
35. -/- mice precedes expression in the colon. J Immunol 2011; 187:5834-5841.
36. Zhuang G, Meng C, Guo X, et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012; 125:2892-2903.
37. Haneklaus M, Gerlic M, Kurowska-Stolarska M, et al. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1 β produc-tion. J Immunol 2012; 189:3795-3799.
38. Takayani H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007; 7:292-304.
39. Suganati T, Hruska KA. Impaired microRNA pathways diminish osteoclast differentiation and function. J Biol Chem 2009; 284:4667-4678.
40. Wua T, Xiea M, Wanga X, et al. miR-155 modulates TNF-α-inhibited osteo-genic differentiation by targeting SOCS1 expression. Bone 2012; 51:498-505.
41. Nakasa T, Shibuya H, Nagata Y, et al. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 2011; 63:1582-1590.
42. Zhang Z, Jimi E, Bothwell AL. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J Immunol 2003; 171:3620-3626.
43. Yen ML, Hsu PN, Liao HJ, et al. TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteo-clast differentiation. PLoS One 2012; 7:e38048.
44. Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000; 343:1594-1602.
45. Hounoki H, Sugiyama E, Mohamed SG, et al. Activation of peroxisome pro-liferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in partviasuppression of mono-cyte chemoattractant protein-1 expression. Bone 2008; 42:765-774.
46. Li YT, Chen SY, Wang CR, et al. Briefreport:amelioration ofcollagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223. Arthritis Rheum 2012; 64:3240-3245.